212 related articles for article (PubMed ID: 32672004)
1. The results of the intensive phase of complete decongestive therapy and the determination of predictive factors for response to treatment in patients with breast cancer related-lymphedema.
Keskin D; Dalyan M; Ünsal-Delialioğlu S; Düzlü-Öztürk Ü
Cancer Rep (Hoboken); 2020 Apr; 3(2):e1225. PubMed ID: 32672004
[TBL] [Abstract][Full Text] [Related]
2. The efficacy of complex decongestive physiotherapy (CDP) and predictive factors of lymphedema severity and response to CDP in breast cancer-related lymphedema (BCRL).
Liao SF; Li SH; Huang HY; Chen ST; Kuo SJ; Chen DR; Wei TS
Breast; 2013 Oct; 22(5):703-6. PubMed ID: 23321586
[TBL] [Abstract][Full Text] [Related]
3. Predictive factors of response to intensive decongestive physiotherapy in upper limb lymphedema after breast cancer treatment: a cohort study.
Vignes S; Porcher R; Champagne A; Dupuy A
Breast Cancer Res Treat; 2006 Jul; 98(1):1-6. PubMed ID: 16752081
[TBL] [Abstract][Full Text] [Related]
4. Predictive factors of response to decongestive therapy in patients with breast-cancer-related lymphedema.
Forner-Cordero I; Muñoz-Langa J; Forner-Cordero A; DeMiguel-Jimeno JM
Ann Surg Oncol; 2010 Mar; 17(3):744-51. PubMed ID: 19859769
[TBL] [Abstract][Full Text] [Related]
5. Long-term management of breast cancer-related lymphedema after intensive decongestive physiotherapy.
Vignes S; Porcher R; Arrault M; Dupuy A
Breast Cancer Res Treat; 2007 Mar; 101(3):285-90. PubMed ID: 16826318
[TBL] [Abstract][Full Text] [Related]
6. Clinical and Scintigraphic Predictors of Primary Lower Limb Lymphedema-Volume Reduction During Complete Decongestive Physical Therapy.
Vignes S; Simon L; Benoughidane B; Simon M; Fourgeaud C
Phys Ther; 2020 May; 100(5):766-772. PubMed ID: 31944248
[TBL] [Abstract][Full Text] [Related]
7. Combined Complete Decongestive Therapy Reduces Volume and Improves Quality of Life and Functional Status in Patients With Breast Cancer-Related Lymphedema.
Borman P; Yaman A; Yasrebi S; Pınar İnanlı A; Arıkan Dönmez A
Clin Breast Cancer; 2022 Apr; 22(3):e270-e277. PubMed ID: 34535391
[TBL] [Abstract][Full Text] [Related]
8. Prospective trial of complete decongestive therapy for upper extremity lymphedema after breast cancer therapy.
Mondry TE; Riffenburgh RH; Johnstone PA
Cancer J; 2004; 10(1):42-8; discussion 17-9. PubMed ID: 15000494
[TBL] [Abstract][Full Text] [Related]
9. Complex decongestive physiotherapy for patients with chronic cancer-associated lymphedema.
Liao SF; Huang MS; Li SH; Chen IR; Wei TS; Kuo SJ; Chen ST; Hsu JC
J Formos Med Assoc; 2004 May; 103(5):344-8. PubMed ID: 15216399
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of Mobiderm Autofit in the Intensive Phase of Breast Cancer-Related Lymphedema Treatment: A Case Series.
Mazur S; Szczęśniak D; Tchórzewska-Korba H
Lymphat Res Biol; 2023 Dec; 21(6):608-613. PubMed ID: 37219879
[No Abstract] [Full Text] [Related]
11. Intensive complete decongestive physiotherapy for cancer-related upper-limb lymphedema: 11 days achieved greater volume reduction than 4.
Vignes S; Blanchard M; Arrault M; Porcher R
Gynecol Oncol; 2013 Oct; 131(1):127-30. PubMed ID: 23906654
[TBL] [Abstract][Full Text] [Related]
12. Clinical effectiveness of decongestive treatments on excess arm volume and patient-centered outcomes in women with early breast cancer-related arm lymphedema: a systematic review.
Jeffs E; Ream E; Taylor C; Bick D
JBI Database System Rev Implement Rep; 2018 Feb; 16(2):453-506. PubMed ID: 29419623
[TBL] [Abstract][Full Text] [Related]
13. Factors influencing breast cancer-related lymphedema volume after intensive decongestive physiotherapy.
Vignes S; Porcher R; Arrault M; Dupuy A
Support Care Cancer; 2011 Jul; 19(7):935-40. PubMed ID: 20495983
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of complete decongestive therapy and manual lymphatic drainage on treatment-related lymphedema in breast cancer.
Koul R; Dufan T; Russell C; Guenther W; Nugent Z; Sun X; Cooke AL
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):841-6. PubMed ID: 17175115
[TBL] [Abstract][Full Text] [Related]
15. The efficacy of complex decongestive physiotherapy (CDP) and predictive factors of response to CDP in lower limb lymphedema (LLL) after pelvic cancer treatment.
Liao SF; Li SH; Huang HY
Gynecol Oncol; 2012 Jun; 125(3):712-5. PubMed ID: 22426250
[TBL] [Abstract][Full Text] [Related]
16. The effect of complex decongestive therapy on spatio-temporal parameters and balance in women with breast cancer-related upper extremity unilateral lymphedema.
Bilek F; Deniz G; Gulkesen A
Clin Biomech (Bristol, Avon); 2023 Feb; 102():105890. PubMed ID: 36669282
[TBL] [Abstract][Full Text] [Related]
17. Complex Decongestive Therapy Enhances Upper Limb Functions in Patients with Breast Cancer-Related Lymphedema.
Sezgin Ozcan D; Dalyan M; Unsal Delialioglu S; Duzlu U; Polat CS; Koseoglu BF
Lymphat Res Biol; 2018 Oct; 16(5):446-452. PubMed ID: 29356592
[TBL] [Abstract][Full Text] [Related]
18. Complex Decongestive Therapy in Breast Cancer-Related Lymphedema: Does Obesity Affect the Outcome Negatively?
Duyur Cakıt B; Pervane Vural S; Ayhan FF
Lymphat Res Biol; 2019 Feb; 17(1):45-50. PubMed ID: 30281384
[TBL] [Abstract][Full Text] [Related]
19. Decongestive lymphatic therapy for patients with cancer-related or primary lymphedema.
Szuba A; Cooke JP; Yousuf S; Rockson SG
Am J Med; 2000 Sep; 109(4):296-300. PubMed ID: 10996580
[TBL] [Abstract][Full Text] [Related]
20. Predictive factors of response to phase I complete decongestive therapy in upper extremity lymphedema following breast carcinoma in Iran.
Haghighat S; Lotfi-Tokaldany M; Maboudi AA; Karami M; Bahadori A; Weiss J
Lymphology; 2013 Jun; 46(2):97-104. PubMed ID: 24354108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
